Medicover Integrated Clinical Servicessp. z o.o.
Research and experimental development on biotechnology
Overview
Financials
Revenue history (in m)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 — this may be an accounting template or the first year of the regime.
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2012-07-01. Active
32 1050 0086 1000 0090 8162 0263- 54 1050 0086 1000 0090 8162 0255
- 30 1050 0086 1000 0090 8510 3860
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
5 public aid cases recorded, with a total value of $31,101.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 11, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,055$1,055 | PREZYDENT MIASTA GDAŃSK | |
| Jun 11, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $811$811 | PREZYDENT MIASTA GDAŃSK | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $9,591$9,591 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Medicover Investment B.v. | 119,280 | $1,611,021.07 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Anna Af Jochnick (46)  | Posiadanie pośrednich uprawnień właścicielskich poprzez uprawnienia w innym podmiocie | |
Peder Af Jochnick (55) | Posiadanie pośrednich uprawnień właścicielskich poprzez uprawnienia w innym podmiocie | |
Hans-Jörg Gatt (57)  | Posiadanie pośrednich uprawnień właścicielskich poprzez uprawnienia w innym podmiocie | |
Christina Meusburger (67) | Posiadanie pośrednich uprawnień właścicielskich poprzez uprawnienia w innym podmiocie | |
Fredrik Stenmo (55) | Posiadanie pośrednich uprawnień właścicielskich poprzez uprawnienia w innym podmiocie |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| RDLSsp. z o.o. | $1,680,515.32 | rdls.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Proper Medical Writingsp. z o.o. | $464,661.64 | propermedicalwriting.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| Getgetsp. z o.o. | — | getget.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-04-24 | Share capital change (50,000.00 PLN → 5,964,000.00 PLN) | |
| 2019-04-25 | Name change (Synevo Central Lab → Medicover Integrated Clinical Services) | |
| 2012-06-26 | Entered in the register |
FAQ
Last updated: 2026-04-23